LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001904.4:c.2009A>G
CTNNB1
· NP_001895.1:p.(Tyr670Cys)
· NM_001904.4
GRCh37: chr3:41278133 A>G
·
GRCh38: chr3:41236642 A>G
Gene:
CTNNB1
Transcript:
NM_001904.4
Final call
VUS
PM2 moderate
BP1 supporting
Variant details
Gene
CTNNB1
Transcript
NM_001904.4
Protein
NP_001895.1:p.(Tyr670Cys)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 moderate: the variant is absent from gnomAD v2.1 and v4.1, below the generic 0.01% threshold.
2
BP1 supporting: CTNNB1 cohorts include 118 truncating versus 4 missense variants, indicating a predominantly truncating disease mechanism.
Final determination:
Under generic ACMG/AMP 2015 rules, one moderate pathogenic criterion plus one supporting benign-direction criterion satisfies neither a pathogenic nor a benign combination, so the call is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: no verified pathogenic variant producing the same CTNNB1 Tyr670Cys amino-acid change was identified. |
PMID:36153650
PMID:40684264
|
| PS2 | Not assessed | Not assessed: no proband phenotype, family-history status, or confirmed maternity and paternity testing is documented for this variant. |
|
| PS3 | Not assessed | Not assessed: functional studies tested Y670F/Y670E or other CTNNB1 variants, not the c.2009A>G (p.Tyr670Cys) substitution. |
PMID:16952352
PMID:21423209
PMID:40684264
|
| PS4 | Not assessed | Not assessed: no exact-variant case-control counts or prevalence comparison were available to calculate the required OR/RR and 95% confidence interval. |
PMID:36153650
PMID:40684264
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM1 | Not met | Not met: Y670 has functional importance, but no qualifying critical domain or statistically significant hotspot was established, and COSMIC reports only one occurrence. |
PMID:16952352
PMID:21423209
hotspots
cosmic
|
| PM2 | Met | Met, Moderate: the variant was absent from gnomAD v2.1 and v4.1, below the <=0.01% PM2 threshold. |
gnomad_v2
gnomad_v4
generic_acmg_combination_rules
|
| PM3 | N/A | Not applicable: CTNNB1 neurodevelopmental disorder is described as autosomal dominant with heterozygous variants, whereas PM3 is restricted to recessive disorders. |
PMID:36153650
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: experimental Y670 substitutions were reported, but no different pathogenic missense change at Tyr670 was verified. |
PMID:16952352
PMID:21423209
PMID:40684264
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no assumed de novo occurrence or parental genotype data are documented for this variant. |
|
| PP1 | Not assessed | Not assessed: zero affected relatives or informative co-segregation meioses are documented for this variant. |
|
| PP2 | Not met | Not met: CTNNB1 disease cohorts show 118 truncating versus 4 missense variants, with a PTC:missense ratio of 29.5 rather than a common missense mechanism. |
PMID:40684264
PMID:36153650
|
| PP3 | Not met | Not met: missense REVEL score 0.44 is below the PP3 supporting threshold of >= 0.644. |
revel
|
| PP4 | Not assessed | Not assessed: no case-specific phenotype or family history was available to show a highly specific CTNNB1 disease presentation. |
PMID:36153650
PMID:40684264
|
| PP5 | Not met | Not met: ClinVar has no exact-variant record, expert-panel submission, or qualifying pathogenic assertion for NM_001904.4:c.2009A>G. |
|
| BA1 | Not met | Not met: the variant was absent from gnomAD v2.1 and v4.1, far below the 5% BA1 threshold. |
gnomad_v2
gnomad_v4
generic_acmg_combination_rules
|
| BS1 | Not met | Not met: gnomAD reported no observed alleles, so filtering allele frequency is 0 and below the generic 1% BS1 threshold. |
gnomad_v2
gnomad_v4
generic_acmg_combination_rules
|
| BS2 | Not assessed | Not assessed: no healthy adult carrying the variant with the required zygosity and early-onset full-penetrance context was documented. |
|
| BS3 | Not assessed | Not assessed: no validated assay directly showed that p.Tyr670Cys has no damaging effect on CTNNB1 protein function or splicing. |
PMID:16952352
PMID:21423209
PMID:40684264
|
| BS4 | Not assessed | Not assessed: no affected relatives with documented absence of the variant are reported. |
|
| BP1 | Met | Met, supporting: CTNNB1 disease data include 118 truncating versus 4 missense variants, a PTC:missense ratio of 29.5. |
PMID:40684264
PMID:36153650
|
| BP2 | Not assessed | Not assessed: no affected-proband observation or phase testing establishes this variant in trans or cis with a pathogenic variant. |
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: missense REVEL score 0.44 is above the BP4 supporting threshold of <= 0.29. |
revel
|
| BP5 | Not met | Not met: no clinical case documents this variant alongside an alternate molecular basis for the disease; the single COSMIC somatic entry is insufficient. |
cosmic
|
| BP6 | Not met | Not met: ClinVar has no exact-variant record, expert-panel submission, or qualifying benign assertion for NM_001904.4:c.2009A>G. |
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.